Immediate Impact

1 by Nobel laureates 7 from Science/Nature 58 standout
Sub-graph 1 of 23

Citing Papers

Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
3 intermediate papers

Works of Laura Aschenbrenner being referenced

RN927C, a Site-Specific Trop-2 Antibody–Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models
2016

Author Peers

Author Last Decade Papers Cites
Laura Aschenbrenner 352 119 121 10 504
Ian Brett 311 133 91 16 515
Donata De Marco 289 71 92 14 514
Y Ina 219 81 89 12 414
Megan E. Gumina 425 118 145 10 568
J. Mao 258 137 65 9 461
A Fukutomi 239 115 99 8 435
Ernst C. Soethout 268 97 205 15 471
Florence Dô 214 105 70 12 440
Mark D. Wareing 291 80 307 13 504
C. Enomoto 404 138 147 11 525

All Works

Loading papers...

Rankless by CCL
2026